SCHEMBL21613442

SCHEMBL21613442

CC(C)=Cc1ncc(-c2ccccc2)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB5 P28074 1/20 0.44
▸ GSK3B P49841 2/20 0.39
▸ GSK3A P49840 1/20 0.39
▸ MAPT P10636 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ CAMKK2 Q96RR4 1/20 0.38
▸ LDHA P00338 1/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ BRD4 O60885 1/20 0.37
▸ PDGFRB P09619 2/20 0.36
▸ USP7 Q93009 1/20 0.36
▸ PDGFRA P16234 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21613439 0.86 MAP4K4 (0.42) MAP4K4GRIN2B
SCHEMBL21613440 0.84 PDGFRB (0.39) MAP4K4PDGFRBPDGFRAGRIN2B
SCHEMBL21613490 0.79 PSMB5 (0.46) PSMB5GSK3BGSK3AMAPTCASP1
SCHEMBL21613445 0.78 PSMB5 (0.45) PSMB5GSK3BGSK3AMAPTCASP1
SCHEMBL23319558 0.75 PSMB5 (0.43) PSMB5GSK3BGSK3AMAPTCASP1
SCHEMBL21613606 0.73 PSMB5 (0.44) PSMB5GSK3BGSK3AMAPTCASP1
SCHEMBL18136475 0.72 PSMB5 (0.53) PSMB5GSK3BGSK3AMAPTCASP1
SCHEMBL23280596 0.71 PSMB5 (0.45) PSMB5GSK3BGSK3AMAPTCASP1
SCHEMBL10205844 0.71 PSMB5 (0.51) PSMB5GSK3BGSK3AMAPTCASP1
SCHEMBL13141949 0.69 PSMB5 (0.50) PSMB5GSK3BGSK3AMAPTCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3319963-B1 SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-01-08 — — EP disclosed
Send feedback